Your session is about to expire
← Back to Search
Genetic Testing and Counseling
Genetic Counseling for Cancer Risk
N/A
Recruiting
Led By Banu Arun, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights
Study Summary
This trial helps Black individuals access genetic testing and counseling to learn their cancer risk and how to reduce it.
Who is the study for?
This trial is for Black or African-American individuals over the age of 18 living in Houston, Texas. Participants must be willing to sign a 'Permission to Contact' form consenting to join the study.Check my eligibility
What is being tested?
The trial aims to use a simple genetic risk screening tool and telegenetics (remote genetic counseling) to connect participants with their hereditary cancer risks for conditions like colorectal and breast cancer.See study design
What are the potential side effects?
Since this trial involves genetic testing and counseling rather than medication or medical procedures, there are no direct physical side effects. However, learning about one's genetic risk can have emotional or psychological impacts.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion; an average of 1 year.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
genetic risk screening tool (GRST) questionnaire
Trial Design
2Treatment groups
Experimental Treatment
Group I: Screening FormExperimental Treatment1 Intervention
Participants will complete a screening form to assess your risk of hereditary breast and colorectal cancers. You will be asked to provide your:
Name and contact information (including your address, phone number, and email)
Demographic information (including your age, race, and ethnicity)
Health insurance status
Annual household income
Personal and family history of cancer, including diagnosis and age at diagnosis
Group II: Genetic Testing and CounselingExperimental Treatment1 Intervention
Participants will be given a saliva collection kit to collect a saliva sample for hereditary cancer and genetic testing.
Find a Location
Who is running the clinical trial?
M.D. Anderson Cancer CenterLead Sponsor
2,974 Previous Clinical Trials
1,788,474 Total Patients Enrolled
147 Trials studying Breast Cancer
62,286 Patients Enrolled for Breast Cancer
Banu Arun, MDPrincipal InvestigatorMD Anderson Cancer Cneter
3 Previous Clinical Trials
262 Total Patients Enrolled
2 Trials studying Breast Cancer
68 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Not applicable.I am over 18, identify as Black or African-American, and have signed the consent form.
Research Study Groups:
This trial has the following groups:- Group 1: Screening Form
- Group 2: Genetic Testing and Counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacant positions available for potential participants of this trial?
"According to the info on clinicaltrials.gov, enrolment for this study is currently open. It was initially posted on November 23rd 2022 and modified as recently as January 20th 2023."
Answered by AI
What is the scope of participants in this experiment?
"Affirmative. According to the information on clinicaltrials.gov, this medical trial is actively recruiting patients as of now. This study was initially posted on November 23rd 2022 and most recently edited on January 20th 2023, with a goal of enrolling 1000 participants from 1 centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger